Dohmen Pascal M, Konertz Wolfgang
Department of Cardiovascular Surgery, Charité Hospital, Medical University, Berlin, Germany.
GMS Krankenhhyg Interdiszip. 2007 Dec 28;2(2):Doc38.
Surgical site infections are a mean topic in cardiac surgery, leading to a prolonged hospitalization, and substantially increased morbidity and mortality. One source of pathogens is the endogenous flora of the patient's skin, which can contaminate the surgical site. A number of preoperative skin care strategies are performed to reduce bacterial contamination like preoperative antiseptic showering, hair removal, antisepsis of the skin, adhesive barrier drapes, and antimicrobial prophylaxis. Furthermore we can also support the natural host defense by optimal intra-operative management of oxygen supply, normoglycemia, and temperature. Nevertheless we still have a number of patients, who develop a surgical site infection. Therefore new skin care strategies are introduced to reduce the contamination by the endogenous skin flora. We present the use of a new microbial sealant, InteguSeal((R)), which was evaluated in patients undergoing cardiac surgery. The preliminary results of this investigation showed a trend in surgical site infection reduction by the use of this new microbial sealant.
手术部位感染是心脏外科手术中的一个重要话题,会导致住院时间延长,并显著增加发病率和死亡率。病原体的一个来源是患者皮肤的内源性菌群,它可能污染手术部位。为减少细菌污染,人们采取了多种术前皮肤护理策略,如术前抗菌沐浴、毛发去除、皮肤消毒、粘贴屏障巾和抗菌预防。此外,我们还可以通过术中优化氧气供应、血糖正常化和体温管理来支持天然宿主防御。然而,我们仍有一些患者发生手术部位感染。因此,引入了新的皮肤护理策略以减少内源性皮肤菌群的污染。我们介绍了一种新型微生物密封剂InteguSeal((R))的使用情况,该密封剂已在接受心脏手术的患者中进行了评估。这项研究的初步结果显示使用这种新型微生物密封剂有降低手术部位感染的趋势。